Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
antitrust
Pharma
Apotex, Heritage fork over $49M to resolve price-fixing claims
A trio of price-fixing complaints have yielded a payoff, with Heritage and Apotex agreeing to lay out a combined $49.1 million in settlement charges.
Fraiser Kansteiner
Nov 1, 2024 10:28am
Warren challenges Novo Holdings' proposed Catalent buyout
Oct 10, 2024 2:16pm
Swiss antitrust regulator drops investigation against Novartis
Oct 10, 2024 9:46am
Glenmark settles with US over longstanding price-fixing claims
Sep 5, 2024 1:31pm
CSL Vifor promises marketing campaign to resolve EU probe
Jul 22, 2024 11:18am
Former FTC director weighs in on $16.5B Novo-Catalent deal
Jul 19, 2024 9:27am
